Table 1 Metabolic parameters of experimental groups at after 4 weeks of treatments.
Parameters | NDS | NDO | HFO | ||||
|---|---|---|---|---|---|---|---|
Ve | E | Vil | Ve | E | Vil | ||
Body weight (g) | 300ā±ā14 | 338ā±ā7* | 304ā±ā8ā | 333ā±ā11* | 393ā±ā10ā | 351ā±ā6ā” | 394ā±ā8 |
Visceral fat (g) | 14.7ā±ā1.4 | 14.5ā±ā1.7 | 11.2ā±ā1.8 | 12.0ā±ā1.0 | 30.8ā±ā1.7ā | 20.5ā±ā2.3ā” | 29.1ā±ā2.9 |
Uterus weight (g) | 0.38ā±ā0.0 | 0.07ā±ā0.0* | 0.40ā±ā0.0ā | 0.06ā±ā0.0* | 0.06ā±ā0.0 | 0.36ā±ā0.0ā” | 0.06ā±ā0.0 |
Glucose (mg/dl) | 130.7ā±ā2.3 | 184.2ā±ā3.5* | 134.4ā±ā3.9ā | 134.0ā±ā3.9ā | 233.4ā±ā4.5ā | 147.1ā±ā4.6ā” | 148.5ā±ā5.5ā” |
Insulin (ng/ml) | 1.06ā±ā0.0 | 2.40ā±ā0.2* | 1.17ā±ā0.0ā | 1.16ā±ā0.5ā | 2.68ā±ā0.2 | 1.26ā±ā0.0ā” | 1.23ā±ā0.0ā” |
HOMA index | 8.42ā±ā0.4 | 21.36ā±ā1.3* | 9.13ā±ā0.5ā | 8.97ā±ā0.6ā | 29.93ā±ā2.1ā | 11.33ā±ā0.4ā” | 10.04ā±ā0.7ā” |
Cholesterol (mg/dl) | 70.4ā±ā3.1 | 101.5ā±ā4.12* | 80.6ā±ā4.6 | 78.4ā±ā4.8 | 160.0ā±ā5.0ā | 145.9ā±ā8.0 | 145.1ā±ā12.6 |
HDL (mg/dl) | 41.7ā±ā2.7 | 32.3ā±ā1.7* | 41.0ā±ā1.8ā | 39.9ā±ā1.7ā | 27.9ā±ā2.4 | 41.0ā±ā3.3ā” | 41.4ā±ā4.1ā” |
LDL (mg/dl) | 29.1ā±ā2.1 | 53.2ā±ā3.3* | 30.9ā±ā6.9ā | 32.9ā±ā6.1ā | 114.4ā±ā4.5ā | 86.2ā±ā5.9ā” | 82.7ā±ā16.8ā” |
Triglyceride (mg/dl) | 50.1ā±ā4.4 | 57.4ā±ā5.9 | 51.2ā±ā5.5 | 51.3ā±ā4.3 | 59.0ā±ā4.9 | 52.3ā±ā3.9 | 52.1ā±ā6.7 |
Estradiol level (pg/ml) | 143ā±ā5 | 53ā±ā3* | 196ā±ā21*ā | 59ā±ā6* | 56ā±ā8 | 202ā±ā24ā” | 53ā±ā11 |
Serum MDA (μmol/ml) | 5.56ā±ā0.2 | 6.18ā±ā0.1* | 5.42ā±ā0.3ā | 5.31ā±ā0.2ā | 6.28ā±ā0.1 | 5.38ā±ā0.2ā” | 5.40ā±ā0.1ā” |
Tissue MDA (μmol/ml) | 4.71ā±ā1.1 | 7.76ā±ā1.1* | 4.48ā±ā0.6ā | 3.85ā±ā0.58ā | 7.94ā±ā1.1 | 4.58ā±ā0.4ā” | 4.63ā±ā0.8ā” |
Food intake (gram/day) | 15.6ā±ā0.0 | 15.2ā±ā0.3 | 14.2ā±ā0.1 | 14.3ā±ā0.3 | 18.6ā±ā0.2ā | 18.6ā±ā0.2 | 17.9ā±ā0.5 |